Genomics

Dataset Information

0

Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients


ABSTRACT: Recurrent mutations in RNA splicing factors SF3B1, U2AF1, and SRSF2 have been reported in hematologic cancers including myelodysplastic syndromes (MDS) and chronic lymphocytic leukemia (CLL). However, SF3B1 is the only splicing associated gene to be found mutated in CLL and has been shown to induce aberrant splicing. To investigate if any other genomic aberration caused similar transcriptome changes, we clustered RNASeq samples based on an alternative 3’ splice site (ss) pattern previously identified in SF3B1-mutant CLL patients. Out of 215 samples, we identified 37 (17%) with alternative 3’ ss usage, the majority of which harbored known SF3B1 hotspot mutations. Interestingly, 3 patient samples carried previously unreported in-frame deletions in SF3B1 around K700, the most frequent mutation hotspot. To study the functional effects of these deletions, we used various minigenes demonstrating that recognition of canonical 3’ ss and alternative branchsite are required for aberrant splicing, as observed for SF3B1 p.K700E. The common mechanism of action of these deletions and substitutions result in similar sensitivity of primary cells towards splicing inhibitor E7107. Altogether, these data demonstrate that novel SF3B1 in-frame deletion events identified in CLL result in aberrant splicing, a common biomarker in spliceosome-mutant cancers.

ORGANISM(S): Homo sapiens

PROVIDER: GSE95352 | GEO | 2017/06/27

SECONDARY ACCESSION(S): PRJNA376727

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-72790 | biostudies-arrayexpress
| E-MTAB-4097 | biostudies-arrayexpress
| PRJNA376606 | ENA
| EGAD00001004398 | EGA
| EGAS00001002932 | EGA
2020-05-01 | GSE116391 | GEO
2015-09-08 | GSE72790 | GEO
2022-10-01 | GSE185713 | GEO
2023-08-08 | GSE190087 | GEO
2023-04-19 | PXD019046 | Pride